-
平臺(tái)編號(hào)：bio-47798
-
國(guó)際編號(hào)：ATCC 50142
-
拉丁屬名： Trichomonas vaginalis
-
規(guī)格：frozen
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
Trichomonas vaginalis
ATCC? Number:50142?
Organism: Trichomonas vaginalis Donne
Designations: RU 393
Isolation: human, New York, 1983
Depositors: M Muller
History: ATCC<<--M Muller<<--Mason
Biosafety Level:2
Shipped: frozen
Growth Conditions: ATCCmedium 2154: LYI Entamoeba mediumTemperature: 35.0°C Duration: axenic; anaerobic Protocol: at pH 6.0
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments: In vitro susceptibility of metronidazole [58183] Antioxidant defences [21764]
References: 21764: Ellis JE, et al. Antioxidant defences in the microaerophilic protozoan Trichomonas vaginalis: comparison of metronidazole-resistant and sensitive strains. Microbiology 140: 2489-2494, 1994. PubMed: 7952198 23976: Muller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery 93: 165-171, 1983. PubMed: 6849201 58183: Muller M, et al. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. 15: 17-24, 1988. PubMed: 3258675 70305: Davis-Hayman SR, et al. Trichomonas vaginalis: analysis of a heat-inducible member of the cytosolic heat-shock-protein 70 multigene family. Parasitol. Res. 86: 608-612, 2000. PubMed: 10935914 70353: Bouma MJ, et al. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus. J. Antimicrob. Chemother. 42: 817-820, 1998. PubMed: 10052908 70372: Adagu IS, et al. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. 49: 103-111, 2002. PubMed: 11751773
ATCC50142
Organism: Trichomonas vaginalis Donne
Designations: RU 393
Isolation: human, New York, 1983
Depositors: M Muller
History: ATCC<<--M Muller<<--Mason
Biosafety Level:2
Shipped: frozen
Growth Conditions: ATCCmedium 2154: LYI Entamoeba mediumTemperature: 35.0°C Duration: axenic; anaerobic Protocol: at pH 6.0
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments: In vitro susceptibility of metronidazole [58183] Antioxidant defences [21764]
References: 21764: Ellis JE, et al. Antioxidant defences in the microaerophilic protozoan Trichomonas vaginalis: comparison of metronidazole-resistant and sensitive strains. Microbiology 140: 2489-2494, 1994. PubMed: 7952198 23976: Muller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery 93: 165-171, 1983. PubMed: 6849201 58183: Muller M, et al. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. 15: 17-24, 1988. PubMed: 3258675 70305: Davis-Hayman SR, et al. Trichomonas vaginalis: analysis of a heat-inducible member of the cytosolic heat-shock-protein 70 multigene family. Parasitol. Res. 86: 608-612, 2000. PubMed: 10935914 70353: Bouma MJ, et al. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus. J. Antimicrob. Chemother. 42: 817-820, 1998. PubMed: 10052908 70372: Adagu IS, et al. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. 49: 103-111, 2002. PubMed: 11751773
ATCC50142
